"We're in a time of transition, and the time is right for male contraception to really move out and get onto the market," says Heather Vahdat, executive director of advocacy group the Male Contraceptive Initiative.
"Most women know that treatments for men and women are often viewed differently, like how insurers have covered birth control compared to Viagra," says Darlene Walley, CEO of Next Life Sciences' Plan A.
Trump's Health and Human Services nominee Robert F. Kennedy Jr., is poised to overhaul the FDA and its drug approvals process just as new treatments seek the FDA's signoff.
New options for male birth control are finally getting closer to market-just as the second Trump administration enters the White House.
Collection
[
|
...
]